Selected research
Industry Research
Transthyretin Industry Research Report 2026
Market perspective
The global Transthyretin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Transthyretin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Transthyretin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Transthyretin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Transthyretin include Alnylam Pharmaceuticals Inc, Arcturus Therapeutics Inc, Ionis Pharmaceuticals Inc, Neurimmune Holding AG, Prothena Corp Plc, Regeneron Pharmaceuticals Inc and Pfizer Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Transthyretin market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Transthyretin Market by Company
Alnylam Pharmaceuticals Inc
Arcturus Therapeutics Inc
Ionis Pharmaceuticals Inc
Neurimmune Holding AG
Prothena Corp Plc
Regeneron Pharmaceuticals Inc
Pfizer Inc
Transthyretin Segment by Type
AG-10
Inotersen Sodium
EDE-1307
CRX-1008
ALN-TTRsc02
Others
Transthyretin Segment by Application
Alzheimer's Disease
Familial Amyloid Neuropathies
Cardomyopathy
Neuropathy
Others
Transthyretin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transthyretin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transthyretin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transthyretin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Transthyretin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Transthyretin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Transthyretin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- AG-10
- Inotersen Sodium
- EDE-1307
- CRX-1008
- ALN-TTRsc02
- Others
Applications
- Alzheimer's Disease
- Familial Amyloid Neuropathies
- Cardomyopathy
- Neuropathy
- Others
Companies covered
- Alnylam Pharmaceuticals Inc
- Arcturus Therapeutics Inc
- Ionis Pharmaceuticals Inc
- Neurimmune Holding AG
- Prothena Corp Plc
- Regeneron Pharmaceuticals Inc
- Pfizer Inc
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Transthyretin Market Size (2021-2032)
- 2.2.2 Global Transthyretin Sales (2021-2032)
- 2.2.3 Global Transthyretin Market Average Price (2021-2032)
- 2.3 Transthyretin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 AG-10
- 2.3.3 Inotersen Sodium
- 2.3.4 EDE-1307
- 2.3.5 CRX-1008
- 2.3.6 ALN-TTRsc02
- 2.3.7 Others
- 2.4 Transthyretin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Alzheimer's Disease
- 2.4.3 Familial Amyloid Neuropathies
- 2.4.4 Cardomyopathy
- 2.4.5 Neuropathy
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Transthyretin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Transthyretin Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Transthyretin Revenue of Manufacturers (2021-2026)
- 3.4 Global Transthyretin Average Price by Manufacturers (2021-2026)
- 3.5 Global Transthyretin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Transthyretin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Transthyretin, Product Type & Application
- 3.8 Global Manufacturers of Transthyretin, Established Date
- 3.9 Global Transthyretin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Alnylam Pharmaceuticals Inc
- 4.1.1 Alnylam Pharmaceuticals Inc Company Information
- 4.1.2 Alnylam Pharmaceuticals Inc Business Overview
- 4.1.3 Alnylam Pharmaceuticals Inc Transthyretin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Alnylam Pharmaceuticals Inc Transthyretin Product Portfolio
- 4.1.5 Alnylam Pharmaceuticals Inc Recent Developments
- 4.2 Arcturus Therapeutics Inc
- 4.2.1 Arcturus Therapeutics Inc Company Information
- 4.2.2 Arcturus Therapeutics Inc Business Overview
- 4.2.3 Arcturus Therapeutics Inc Transthyretin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Arcturus Therapeutics Inc Transthyretin Product Portfolio
- 4.2.5 Arcturus Therapeutics Inc Recent Developments
- 4.3 Ionis Pharmaceuticals Inc
- 4.3.1 Ionis Pharmaceuticals Inc Company Information
- 4.3.2 Ionis Pharmaceuticals Inc Business Overview
- 4.3.3 Ionis Pharmaceuticals Inc Transthyretin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Ionis Pharmaceuticals Inc Transthyretin Product Portfolio
- 4.3.5 Ionis Pharmaceuticals Inc Recent Developments
- 4.4 Neurimmune Holding AG
- 4.4.1 Neurimmune Holding AG Company Information
- 4.4.2 Neurimmune Holding AG Business Overview
- 4.4.3 Neurimmune Holding AG Transthyretin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Neurimmune Holding AG Transthyretin Product Portfolio
- 4.4.5 Neurimmune Holding AG Recent Developments
- 4.5 Prothena Corp Plc
- 4.5.1 Prothena Corp Plc Company Information
- 4.5.2 Prothena Corp Plc Business Overview
- 4.5.3 Prothena Corp Plc Transthyretin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Prothena Corp Plc Transthyretin Product Portfolio
- 4.5.5 Prothena Corp Plc Recent Developments
- 4.6 Regeneron Pharmaceuticals Inc
- 4.6.1 Regeneron Pharmaceuticals Inc Company Information
- 4.6.2 Regeneron Pharmaceuticals Inc Business Overview
- 4.6.3 Regeneron Pharmaceuticals Inc Transthyretin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Regeneron Pharmaceuticals Inc Transthyretin Product Portfolio
- 4.6.5 Regeneron Pharmaceuticals Inc Recent Developments
- 4.7 Pfizer Inc
- 4.7.1 Pfizer Inc Company Information
- 4.7.2 Pfizer Inc Business Overview
- 4.7.3 Pfizer Inc Transthyretin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Pfizer Inc Transthyretin Product Portfolio
- 4.7.5 Pfizer Inc Recent Developments
5 Global Transthyretin Market Scenario by Region
- 5.1 Global Transthyretin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Transthyretin Sales by Region: 2021-2032
- 5.2.1 Global Transthyretin Sales by Region: 2021-2026
- 5.2.2 Global Transthyretin Sales by Region: 2027-2032
- 5.3 Global Transthyretin Revenue by Region: 2021-2032
- 5.3.1 Global Transthyretin Revenue by Region: 2021-2026
- 5.3.2 Global Transthyretin Revenue by Region: 2027-2032
- 5.4 North America Transthyretin Market Facts & Figures by Country
- 5.4.1 North America Transthyretin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Transthyretin Sales by Country (2021-2032)
- 5.4.3 North America Transthyretin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Transthyretin Market Facts & Figures by Country
- 5.5.1 Europe Transthyretin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Transthyretin Sales by Country (2021-2032)
- 5.5.3 Europe Transthyretin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Transthyretin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Transthyretin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Transthyretin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Transthyretin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Transthyretin Market Facts & Figures by Country
- 5.7.1 South America Transthyretin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Transthyretin Sales by Country (2021-2032)
- 5.7.3 South America Transthyretin Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Transthyretin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Transthyretin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Transthyretin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Transthyretin Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Transthyretin Sales by Type (2021-2032)
- 6.1.1 Global Transthyretin Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Transthyretin Sales Market Share by Type (2021-2032)
- 6.2 Global Transthyretin Revenue by Type (2021-2032)
- 6.2.1 Global Transthyretin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Transthyretin Revenue Market Share by Type (2021-2032)
- 6.3 Global Transthyretin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Transthyretin Sales by Application (2021-2032)
- 7.1.1 Global Transthyretin Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Transthyretin Sales Market Share by Application (2021-2032)
- 7.2 Global Transthyretin Revenue by Application (2021-2032)
- 7.2.1 Global Transthyretin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Transthyretin Revenue Market Share by Application (2021-2032)
- 7.3 Global Transthyretin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Transthyretin Value Chain Analysis
- 8.1.1 Transthyretin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Transthyretin Production Mode & Process
- 8.2 Transthyretin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Transthyretin Distributors
- 8.2.3 Transthyretin Customers
9 Global Transthyretin Analyzing Market Dynamics
- 9.1 Transthyretin Industry Trends
- 9.2 Transthyretin Industry Drivers
- 9.3 Transthyretin Industry Opportunities and Challenges
- 9.4 Transthyretin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst